) A loss on ignition analyses of a batch of aspirin tablets indicates: 0.2 % inorganic residue is?

... contained in the sample. If the aspirin tablets were packaged in aluminium blister packs, what would be the source of the inorganic residue? How would the presence of such an inorganic residue in the aspirin tablets influence the bioavailability of the active pharmaceutical ingredient?